These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3123387)

  • 1. Immunological analysis of cell-associated antigens of Bacillus anthracis.
    Ezzell JW; Abshire TG
    Infect Immun; 1988 Feb; 56(2):349-56. PubMed ID: 3123387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization studies with attenuated strains of Bacillus anthracis.
    Ivins BE; Ezzell JW; Jemski J; Hedlund KW; Ristroph JD; Leppla SH
    Infect Immun; 1986 May; 52(2):454-8. PubMed ID: 3084383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen.
    Ivins BE; Welkos SL; Knudson GB; Little SF
    Infect Immun; 1990 Feb; 58(2):303-8. PubMed ID: 2105269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S; Little S; Friedlander A; Fritz D; Fellows P
    Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
    Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.
    Little SF; Knudson GB
    Infect Immun; 1986 May; 52(2):509-12. PubMed ID: 3084385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Bacillus anthracis by polyclonal antibodies against extracted vegetative cell antigens.
    Phillips AP; Ezzell JW
    J Appl Bacteriol; 1989 May; 66(5):419-32. PubMed ID: 2502530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs.
    Ivins BE; Fellows PF; Nelson GO
    Vaccine; 1994 Aug; 12(10):872-4. PubMed ID: 7975827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis.
    Singh Y; Ivins BE; Leppla SH
    Infect Immun; 1998 Jul; 66(7):3447-8. PubMed ID: 9632621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of Bacillus anthracis surface protein EA1 against anthrax in mice.
    Uchida M; Harada T; Enkhtuya J; Kusumoto A; Kobayashi Y; Chiba S; Shyaka A; Kawamoto K
    Biochem Biophys Res Commun; 2012 May; 421(2):323-8. PubMed ID: 22507985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
    Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE
    FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia.
    Cote CK; Kaatz L; Reinhardt J; Bozue J; Tobery SA; Bassett AD; Sanz P; Darnell SC; Alem F; O'Brien AD; Welkos SL
    J Med Microbiol; 2012 Oct; 61(Pt 10):1380-1392. PubMed ID: 22767539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
    Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs.
    Little SF; Ivins BE; Fellows PF; Friedlander AM
    Infect Immun; 1997 Dec; 65(12):5171-5. PubMed ID: 9393812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity.
    Turnbull PC; Broster MG; Carman JA; Manchee RJ; Melling J
    Infect Immun; 1986 May; 52(2):356-63. PubMed ID: 3084381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
    Ndumnego OC; Köhler SM; Crafford J; van Heerden H; Beyer W
    Vet Immunol Immunopathol; 2016 Oct; 178():14-21. PubMed ID: 27496738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
    Enkhtuya J; Kawamoto K; Kobayashi Y; Uchida I; Rana N; Makino SI
    Microbiology (Reading); 2006 Oct; 152(Pt 10):3103-3110. PubMed ID: 17005989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants.
    Ivins BE; Welkos SL; Little SF; Crumrine MH; Nelson GO
    Infect Immun; 1992 Feb; 60(2):662-8. PubMed ID: 1730501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Bacillus anthracis extractable antigen for testing anthrax immunity.
    Shlyakhov E; Shoenfeld Y; Gilburd B; Rubinstein E
    Clin Microbiol Infect; 2004 May; 10(5):421-4. PubMed ID: 15113319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin.
    Fellows PF; Linscott MK; Ivins BE; Pitt ML; Rossi CA; Gibbs PH; Friedlander AM
    Vaccine; 2001 Apr; 19(23-24):3241-7. PubMed ID: 11312020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.